Clinical Trials Directory

Trials / Conditions / Hormone Receptor Positive Breast Adenocarcinoma

Hormone Receptor Positive Breast Adenocarcinoma

7 registered clinical trials studyying Hormone Receptor Positive Breast Adenocarcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
NCT07020117
Aktis Oncology, Inc.Phase 1
RecruitingStudy of 68Ga-R10602
NCT06745804
Radionetics OncologyPhase 1
RecruitingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan
NCT06805812
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano—
CompletedAbemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast C
NCT04481113
OHSU Knight Cancer InstitutePhase 1
WithdrawnImmunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positiv
NCT04756505
M.D. Anderson Cancer CenterPhase 1
TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
NCT04789668
M.D. Anderson Cancer CenterPhase 1 / Phase 2
TerminatedImpact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and H
NCT04876378
University of California, San Francisco—